瀏覽量: 71
- 產(chǎn)品名稱: KL-11743
- 產(chǎn)品貨號(hào): CS01459
- 貨期: 現(xiàn)貨
- 價(jià)格與訂購(gòu): 1500
- 數(shù)量:
- 規(guī)格: 5mg
- 產(chǎn)品信息
- 如何訂購(gòu)
產(chǎn)品描述
KL-11743 is a potent, orally active, and glucose-competitive inhibitor of the class I glucose transporters, with IC50s of 115, 137, 90, and 68 nM for GLUT1, GLUT2, GLUT3, and GLUT4, respectively. KL-11743 specifically blocks glucose metabolism. KL-11743 can synergize with electron transport inhibitors to induce cell death[1][2][3].
分子量
522.60
分子式
C30H30N6O3
結(jié)構(gòu)式
CAS No.
1369452-53-8
性狀
固體
顏色
Light yellow to green yellow
純度
98%
運(yùn)輸條件
Room temperature in continental US; may vary elsewhere.
儲(chǔ)存條件
Powder: -20°C for 3 years,4°C for 2 years ;In solvent: -80°C for 6 montha,-20°C for 1 month|.
參考文獻(xiàn)
[1]. Liu KG, et, al. Discovery and Optimization of Glucose Uptake Inhibitors. J Med Chem. 2020 May 28;63(10):5201-5211.
[2]. Liu X, et, al. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat Cell Biol. 2020 Apr;22(4):476-486.
[3]. Olszewski K, et, al. Inhibition of glucose transport synergizes with chemical or genetic disruption of mitochondrial metabolism and suppresses TCA cycle-deficient tumors. Cell Chem Biol. 2021 Oct 22;S2451-9456(21)00441-4.
Note
For research use only.